BTW, might be time for you to look at CYP under 50c again. Think it's time for a turnaround, and expecting a very good 2022 from low base. Chart looking ripe for reversal. (cant get much worse!)
Lots trials happening. US GvHD FDA/IND will give it a good kick Q1 next year imo and get on more radars. New wound care trial starting now ARDs/Covid trial about to finish and get some readout Q1 also Ongoing Large Phase 3 in OA
Cap around $70m Cash $30m
Super undervalued EV at under $40m now. 4 trials happening. My best tip for 2022 at present...but like I mentioned with PSC, I didn't tip it for 4 weeks, as too short for my timeframes these days. another 6-12 month bagger.
